Abstract: The present invention refers to an improved process for the preparation of a crystalline form of Fluvastatin sodium salt. Moreover, it is also related to a novel Fluvastatin sodium salt crystalline form and a process for the preparation thereof.
Type:
Application
Filed:
March 13, 2024
Publication date:
September 26, 2024
Applicant:
F.I.S. - FABBRICA ITALIANA SINTETICI S.P.A.
Inventors:
Nicolas TESSON, Montserrat TRILLA CASTAÑO, Riccardo MOTTERLE, Paolo STABILE
Abstract: Object of the present invention is an improved process for the preparation of Trenbolone (I-b) and/or Trenbolone Acetate (I-a) comprising the reaction of the compound of formula (II): wherein R is H or Ac; with an oxidant agent in presence of an acid.
Type:
Application
Filed:
November 18, 2021
Publication date:
January 25, 2024
Applicant:
F.I.S. - FABBRICA ITALIANA SINTETICI S.P.A.
Abstract: Highly efficient process for the preparation of 4-Fluoro-1H-pyrazole or salts thereof by reaction of pyrazole with an electrophilic fluorinating reagent is disclosed.
Type:
Application
Filed:
January 27, 2023
Publication date:
August 3, 2023
Applicant:
F.I.S. - Fabbrica Italiana Sintetici S.p.A.
Abstract: Object of the present invention is a highly stable crystalline form of Eltrombopag (ETP) monoethanolamine salt, named Form D1, having the highest thermodynamically stability with excellent non-hygroscopicity, and particularly well suitable for pharmaceutical purposes, with related process.
Type:
Application
Filed:
July 25, 2019
Publication date:
September 16, 2021
Applicant:
F.I.S. - FABBRICA ITALIANA SINTETICI S.P.A.
Inventors:
Nicolas TESSON, Jordi DE MIER VINUE, Paolo STABILE, Pierluigi PADOVAN, Matteo DE POLI, Angelo RESTELLI
Abstract: Object of the present invention is a better crystalline form of Eltrombopag (ETP) monoethanolamine salt, named Form D, stable, suitable for pharmaceutical purposes, and with the highest solubility in water and excellent non-hygroscopicity, then the related process and intermediates thereof.
Type:
Application
Filed:
July 25, 2019
Publication date:
July 1, 2021
Applicant:
F.I.S. - FABBRICA ITALIANA SINTETICI S.P.A.
Inventors:
Nicolas TESSON, Jordi DE MIER VINUE, Paolo STABILE, Pierluigi PADOVAN, Matteo DE POLI, Angelo RESTELLI
Abstract: The present invention relates to a process for the preparation of Droxidopa by means of an improved enzymatic reduction of a compound of formula (II): (II), wherein R1, R2 is independent hydrogen, acetyl, R3 is hydrogen, a C1-C4 linear or branched alkyl group and R4 is hydrogen or an amine protecting group.
Type:
Application
Filed:
June 7, 2019
Publication date:
June 3, 2021
Applicant:
F.I.S. - FABBRICA ITALIANA SINTETICI S.P.A.
Inventors:
Stefano FOGAL, Paolo STABILE, Pierluigi PADOVAN, Matteo DE POLI, Angelo RESTELLI
Abstract: Object of the present invention is an efficient process for the preparation of the active pharmaceutical ingredient Sitagliptine and the 2,4,5-trifluorophenylacetic acid (TFAA) and salt thereof, which is a key intermediate for the synthesis of Sitagliptine.
Type:
Application
Filed:
January 11, 2019
Publication date:
March 4, 2021
Applicant:
F.I.S. - FABBRICA ITALIANA SINTETICI S.P.A.
Inventors:
Terry SHI, Sam LOU, Ottorino DE LUCCHI, Pierluigi PADOVAN
Abstract: Object of the present invention is an efficient process for the preparation of the active pharmaceutical ingredient Sitagliptine and the 2,4,5-trifluorophenylacetic acid (TFAA) and salt thereof, which is a key intermediate for the synthesis of Sitagliptine.
Type:
Application
Filed:
May 15, 2018
Publication date:
May 21, 2020
Applicant:
F.I.S. - FABBRiCA ITALIANA SINTETICI S.P.A.
Inventors:
Ottorino DE LUCCHI, Pierluigi PADOVAN, Elena BRASOLA
Abstract: Object of the present invention are dimer impurities of the active ingredient Apixaban, analytical methods for identifying and/or quantifying them and a synthetic method for removing or limiting said impurities from Apixaban and synthetic precursors thereof.
Type:
Grant
Filed:
June 28, 2019
Date of Patent:
March 17, 2020
Assignee:
F.I.S.-FABBRICA ITALIANA SINTETICI S.P.A.
Inventors:
Elena Brasola, Filippo Tomasi, Loris Peruzzi
Abstract: Object of the present invention is an improved process for the preparation of (3R,4R)-1-benzyl-4-methylpiperidin-3-amine by means of chiral Rhodium catalysts.
Type:
Application
Filed:
June 25, 2018
Publication date:
January 3, 2019
Applicant:
F.I.S. - Fabbrica Italiana Sintetici S.p.A.
Inventors:
Mireia Pastó Aguilà, Sara Preciado Gallego, Emanuele Miserazzi
Abstract: Object of the present invention is a process for the preparation of the pharmaceutical active ingredient Nilotinib free base or Nilotinib dihydrochloride dihydrate by means of an improved crystallization procedure.
Type:
Application
Filed:
May 15, 2018
Publication date:
November 22, 2018
Applicant:
F.I.S. - Fabbrica Italiana Sintetici S.p.A.
Abstract: Object of the present invention is an improved process for the preparation of Apixaban, through new intermediates which undergo to a faster amidation reaction. Impurities of Apixaban are also identified and quantified.
Type:
Grant
Filed:
November 30, 2017
Date of Patent:
August 7, 2018
Assignee:
F.I.S. FABBRICA ITALIANA SINTETICI S.P.A.
Abstract: Object of the present invention are dimer impurities of the active ingredient Apixaban, analytical methods for identifying and/or quantifying them and a synthetic method for removing or limiting said impurities from Apixaban and synthetic precursors thereof.
Type:
Application
Filed:
July 18, 2016
Publication date:
May 3, 2018
Applicant:
F.I.S. - FABBRICA ITALIANA SINTETICI S.P.A.
Inventors:
Elena BRASOLA, Filippo TOMASI, Loris PERUZZI
Abstract: The present invention refers to a new efficient process for the synthesis of the active pharmaceutical ingredient Lapatinib and salts thereof. In particular, the present synthesis is carried out employing new intermediates in which the amine function is protected by a group cleavable in basic milieu that provides a higher overall yield of the synthesis process.
Type:
Application
Filed:
July 21, 2015
Publication date:
November 12, 2015
Applicant:
F.I.S. - Fabbrica Italiana Sintetici S.p.A.
Abstract: The present invention refers to a new efficient process for the synthesis of the active pharmaceutical ingredient Lapatinib and salts thereof. In particular, the present synthesis is carried out employing new intermediates in which the amine function is protected by a group cleavable in basic milieu that provides a higher overall yield of the synthesis process.
Type:
Application
Filed:
February 18, 2015
Publication date:
August 13, 2015
Applicant:
F.I.S. - Fabbrica Italiana Sintetici S.p.A.
Abstract: The present invention refers to a new efficient process for the synthesis of the active pharmaceutical ingredient Lapatinib and salts thereof. In particular, the present synthesis is carried out employing new intermediates in which the amine function is protected by a group cleavable in basic milieu that provides a higher overall yield of the synthesis process.
Type:
Application
Filed:
September 3, 2013
Publication date:
March 5, 2015
Applicant:
F.I.S. - Fabbrica Italiana Sintetici S.p.A.